To include your compound in the COVID-19 Resource Center, submit it here.

Vical, Astellas deal

Vical granted Astellas exclusive, worldwide rights to develop and commercialize Vical's TransVax cytomegalovirus

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE